# Top 50 Medical Startup Investors in Australia in June 2026

## Brandon Capital
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 12
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

## Artesian VC
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 9
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Health Care

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

## Medical Research Commercialisation Fund (MRCF)
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 7
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

## Uniseed
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 6
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Manufacturing

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ).  This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities.  Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund.   The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation).  Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets.  It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide.  They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes.  Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## Uniseed Ventures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 5
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Manufacturing

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## Giant Leap Fund
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Health Care, Information Technology, Software

Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.

## Breakthrough Victoria
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Health Care, Manufacturing, Biotechnology

The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

## Stoic VC
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Biotechnology, Medical, Health Care

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

## Main Sequence Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, Manufacturing

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

## Transition Level Investments
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: SaaS, Software, Health Care

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

## Fund WA
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Medical, Health Care, Manufacturing

FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.

## Right Click Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Software, SaaS, Information Technology

Right Click Capital - Australian Venture Capital Firm

## Antler
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 3
- Stages: Pre-Seed, Seed, Series A
- Focus: Software, Artificial Intelligence, Information Technology

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

## EVP
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 3
- Stages: Series A, Seed
- Focus: Software, SaaS, Information Technology

EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.

## M8 Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, SaaS, Medical

Great tech startup businesses are built by   amazing product teams

## Regal Funds Management
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Convertible Note, Series B
- Focus: Software, Financial Services, FinTech

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Software, Artificial Intelligence

Investing in the deep science and technology that can propel humanity towards a radically better future.

## Tyson & Blake
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed
- Focus: Medical, Facial Recognition, Artificial Intelligence

Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.

## Jolimont Global Mining Systems
- Type: VC Fund
- Location: Denver, Colorado, United States
- Relevant deals: 2
- Stages: Seed, Convertible Note
- Focus: Software, Construction, SaaS

Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.

## Purpose Ventures
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 2
- Stages: Seed
- Focus: EdTech, Medical, Education

Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.

## Kurt Alexander
- Type: Angel
- Location: Brisbane, Queensland, Australia
- Relevant deals: 2
- Stages: Seed
- Focus: Mining, Retail, Medical

Kurt Alexander

## Carthona Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, Financial Services, FinTech

Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.

## Clinton Capital Partners
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, E-Commerce, Health Care

Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.

## Folklore Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Information Technology, Apps

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

## Blackbird Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, SaaS

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

## Sydney Angels
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Angel, Series A
- Focus: Software, SaaS, Health Care

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

## Starfish Ventures
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Software, Enterprise Software, Internet

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

## Australian Medical Angels
- Type: VC Fund
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Machine Learning, Sports

Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.

## Larsen Ventures
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, Education, SaaS

Larsen Ventures is a lean, driven and strategic venture investment firmWe believe in alignment, long-term thinking & investor due diligence

We like metrics, traction & perseverance

We invest in people
1/3 of our focus is on Health and Education;

We like the thematic & overall gains for society2/3 of our time is spentlearning from peers, digging into research,

chasing leads & hanging out on caffeinated zooms in the endless search for;Founders with Traction

Founders with Insight

Founders with Perseverance and Courage

Founders with an innate ability to question EverythingWe have patient capital that engages & contributes to your Journey

Accelerate your business with our portfolios' intellectual capital

## Black Sheep Capital
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed, Series A, Series C
- Focus: Software, Internet, E-Commerce

Black Sheep Capital is making its mark as a preferred investment capital provider due to their 'Everyone Wins' approach. Their philosophy is to work with their investment partners to create and grow opportunities where they can all enjoy success. Through this approach, they have been able to create a diverse portfolio of investments thatcontinues to grow.

## OIF Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Software, SaaS, Internet

OIF is a venture capital firm focusing on partnering with entrepreneurs building businesses.

## Prtnr
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Hospital, Health Care

Prtnr is an investment firm.

## Salus Ventures
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Organic, Robotics, Aerospace

Salus Ventures is a venture capital firm.

## Watermark Funds Management
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Software, Health Care

Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.

## Washington H. Soul Pattinson
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Software, Hotel, Men's

With origins in owning and operating Australian pharmacies, Soul Patts has evolved into a diversified investment house investing across a range of industries and asset classes, including listed equities, private equity, credit, and property.

## Scalare Partners
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, FinTech, Information Technology

Scalare Partners is more than a technology investment fund. We provide critical funding and resourcing 

## Titanium Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series B, Series C, Series A
- Focus: Software, Information Technology, Artificial Intelligence

Titanium Ventures is the results-oriented VC partner to the most promising technology startups. Accelerating extraordinary companies and fueling growth of standout disruptors.

## Melbourne Angels
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Angel, Seed
- Focus: Biotechnology, Information Technology, Internet

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

## Square Peg Capital
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, Artificial Intelligence, Information Technology

Square Peg is a global investment firm on a mission to empower exceptional founders. With investing teams in Sydney, Melbourne, Tel Aviv, and Singapore, Square Peg invests in emerging technology companies across the internet economy.

## Mass Medical Angels
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical Device

Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the lifescience community to achieve superior returns for their group, and more clinical innovation for the community.

## SG Hiscock
- Type: VC Fund
- Relevant deals: 1
- Stages: Series A
- Focus: Software, Legal, Medical

SG Hiscock

## Stephen Baxter
- Type: Angel
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Angel
- Focus: Software, SaaS, Information Technology

Stephen Baxter - Founder @ River City Labs

## Healthcare Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1

Healthcare Ventures is an investment fund that invests in people and technologies that focuses on the data and technology of healthcare. Healthcare Ventures specializes in the fields of venture capital, private equity, and financial services.

## William Welty
- Type: Angel
- Location: Manassas, Virginia, United States
- Relevant deals: 1
- Stages: Seed
- Focus: Mining, Retail, Medical

William Welty

## Lilly Ventures
- Type: VC Fund
- Location: Indianapolis, Indiana, United States
- Relevant deals: 1
- Stages: Series C, Series B, Series A
- Focus: Biotechnology, Health Care, Therapeutics

Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.

## Jutech Pty Ltd
- Type: Angel
- Location: Toowoomba, Queensland, Australia
- Relevant deals: 1
- Stages: Seed
- Focus: Mining, Retail, Medical

Jutech Pty Ltd

## QIC BioVentures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Biotechnology

QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.

## Seven West Media
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 1
- Stages: Seed, Series C
- Focus: Software, Internet, Financial Services

Change the tagline

## CP Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, Artificial Intelligence, Machine Learning

The CP Ventures Fund invests in early-stage technology companies that are highly scalable, at the forefront of breakthrough technologies, and driven by the fourth industrial revolution.

## Li Ka-shing
- Type: Angel
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Food and Beverage

Mr. Li Ka-shing is the richest person of East Asian descent in the world and the 11th richest person in the world with an estimated wealth of US$26 billion (as estimated by Forbes).  His primary operating company is Hutchison Whampoa Limited.  Mr Li's younger son, Richard, is Chairman of PCCW, one of Asia's leading internet andtelecommunications companies.Mr Li Ka-shing is the Chairman of Cheung Kong (Holdings) Limited and Hutchison Whampoa Limited. Cheung Kong (Holdings) Limited is the flagship of the Cheung Kong Group which has business operations in 54 countries around the world and employs about 240,000 staff. In Hong Kong alone, the Group includes nine listed companies with a combined market capitalization of approximately HKD600 billion (30 June 2009). Hutchison Whampoa Limited is a Fortune Global 500 company.Born in 1928 in Chiu Chow, a coastal city in the southeastern part of China, Mr Li fled to Hong Kong with his family to avoid the perils of war. His father suffered from tuberculosis and passed away in Hong Kong. Shouldering the responsibility of looking after the livelihood of the family, Mr Li was forced to leave school before the age of 15 and found a job in a plastics trading company where he labored 16 hours a day. By 1950, his hard work, prudence and his pursuit of excellence had enabled him to start his own company, Cheung Kong Industries. From manufacturing plastics, Mr Li led and developed his company into a leading real estate investment company in Hong Kong that was listed on the Hong Kong Stock Exchange in 1972. Cheung Kong continued to expand by acquiring Hutchison Whampoa and Hongkong Electric Holdings Limited in 1979 and 1985 respectively.Based in Hong Kong, the Cheung Kong Group's businesses encompass such diverse areas as property development and investment, real estate agency and estate management, hotels, telecommunications and e-commerce, finance and investments, retail, ports and related services, energy, infrastructure projects and materials, media, and biotechnology. Mr Li is a strong believer in synergy — the power of combined efforts. This belief is reflected in his naming his company Cheung Kong Holdings after the Yangtze River that flows through China, a great river that aggregates countless streams and tributaries. The Times in the United Kingdom and Ernst & Young UK jointly named Mr Li as the Entrepreneur of the Millennium at the turn of the century.http://www.hutchison-whampoa.com/eng/about/chairman/chairman.htm 30 June 2009